U.S. Rep. Greg Walden (R-Ore.) vows to advocate for legislation aiming to curb drug prices through the development of more generic drugs, reports The Wall Street Journal.
Supply Chain
Amgen's cholesterol drug Repatha proved effective at lowering the risk of heart attacks, strokes and death in patients with heart disease in a recent clinical trial, reports Reuters.
Cambridge, Mass.-based Biogen received a subpoena on Dec. 5 from federal investigators requesting information on the price of its multiple sclerosis drugs, reports Boston Business Journal.
As a vocal critic of high drug prices, President Trump has shared many remarks about the pharmaceutical industry, along with solutions to decrease costs.
The Food and Drug Administration approved Bristol-Myers Squibb's best-selling cancer drug Opdivo to treat urothelial carcinoma — the most common type of bladder cancer, reports Reuters.
Advertisement
Here are seven drugs and medical devices approved by the Food and Drug Administration since Jan. 18.
New York City-based Pfizer is considering the sale of several cardiology, urology and primary care treatments, a source told Bloomberg.
Premier, a Charlotte, N.C.-based group purchasing organization, awarded Diversey Care a three-year contract for its Taski and Intellibot floor care equipment.
The Food and Drug Administration gave Abbott approval to label its Assurity MRI pacemaker and the Tendril MRI pacing lead as MRI-compatible.
Sun Pharmaceutical Industries issued a voluntary recall of its anti-depressant drug bupropion hydrochloride in the U.S., reports CNBC's Money Control.